OneMedNet Corporation Announces 1-for-10 Reverse Stock Split

Shareholders’ relative interests will remain unchanged, except for fractional-share adjustments.

Rhea-AI Summary

OneMedNet (ONMD) will implement a 1-for-10 reverse split of its common shares, effective September 29, 2026.

The split will combine every 10 outstanding shares into one. Outstanding shares will fall from approximately 59,286,450 as of September 24, 2026, to approximately 5,928,645. The authorized share count will not change. Stockholders approved the split on September 18, and the board selected the final ratio. OneMedNet says the split is intended to meet the Nasdaq Capital Market’s minimum bid price requirement for continued listing and broaden investor interest. Split-adjusted trading is expected to begin September 29 under ONMD, with CUSIP number 68270C 202.

Argus 15 min delay 11 alerts

-0.74% vs previous close $0.70 last price 13.2x rel. volume Open Argus

Details

Market Reaction – ONMD

-6.0% Trough in 0 min

$0.62 $0.73 Day Range

$41.49M Market Cap

On Sep 25, the day this news came out, the latest delayed price for ONMD is 0.74% below the previous close. Argus tracked a trough of -6.0% from its starting point during tracking. Our momentum scanner has recorded 11 alerts for this stock so far that day. The latest delayed price is $0.70. Relative volume is exceptionally heavy at 13.2x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Reverse split ratio: 1-for-10 Effective time: 12:01 a.m. Eastern Time on September 29, 2026 Shares outstanding before split: Approximately 59,286,450 shares +1 more

Reverse split ratio

1-for-10

Effective September 29, 2026

Effective time

12:01 a.m. Eastern Time on September 29, 2026

Reverse stock split milestone

Shares outstanding before split

Approximately 59,286,450 shares

As of September 24, 2026

Shares outstanding after split

Approximately 5,928,645 shares

Following the reverse stock split

Key Terms

reverse stock split, cusip number, par value, restricted stock units, +1 more

5 terms

reverse stock split financial

"implement a 1-for-10 reverse stock split of its issued and outstanding shares"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

cusip number technical

"with the new CUSIP number 68270C 202"

A CUSIP number is a nine-character code that uniquely identifies a specific U.S. or Canadian stock, bond, or other security, similar to a barcode or a social-security number for a financial instrument. It matters to investors because it removes confusion between similar securities, ensures trades and settlements are applied to the correct issue, and helps locate official documents and transaction records quickly.

par value financial

"without any change in the par value per share"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

restricted stock units financial

"outstanding restricted stock units, warrants, and other equity instruments"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

real-world data technical

"AI-driven Real-World Data (RWD), today announced"

Real-world data consists of information collected from everyday sources outside of controlled experiments or official reports, such as patient records, insurance claims, or wearable device readings. For investors, it provides a more complete picture of how products and services perform in actual use, helping them make better-informed decisions based on how things work in real life rather than just in theory or controlled settings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Sept. 25, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “Company,” “we,” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced that it will implement a 1-for-10 reverse stock split of its issued and outstanding shares of common stock (the “Reverse Stock Split”), effective at 12:01 a.m. Eastern Time on September 29, 2026. The Reverse Stock Split was approved by the Company’s stockholders at its Annual Meeting of Stockholders held on September 18, 2026, with the final ratio, within the range approved by stockholders, subsequently determined by the Company’s board of directors. The Reverse Stock Split is intended to bring the Company into compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, and to broaden investor interest.

The Company’s common stock is expected to begin trading on a split-adjusted basis when the markets open on September 29, 2026 under the Company’s existing trading symbol “ONMD” with the new CUSIP number 68270C 202.

At the effective time of the Reverse Stock Split, every ten (10) shares of the Company’s issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock without any change in the par value per share. The Reverse Split will reduce the number of shares of outstanding common stock from approximately 59,286,450 shares, the number of shares outstanding as of September 24, 2026, to approximately 5,928,645 shares of common stock. The total authorized number of shares will not be reduced. The Reverse Stock Split will also proportionately adjust the number of shares available under the Company’s equity incentive plans and the exercise price and number of shares underlying outstanding restricted stock units, warrants, and other equity instruments, in each case in accordance with their terms.

No fractional shares will be issued in connection with the Reverse Stock Split. Any fractional shares of common stock resulting from the Reverse Stock Split will be rounded up to the nearest whole share. The Reverse Stock Split will affect all stockholders uniformly and will not alter any stockholder’s relative interest in the Company’s equity securities, except for any adjustments for fractional shares.

Continental Stock Transfer & Trust Company is acting as the exchange agent and transfer agent for the Reverse Stock Split. Stockholders holding their shares electronically are not required to take any action to receive post-split shares. Stockholders owning shares through a bank, broker or other nominee will have their positions adjusted to reflect the Reverse Stock Split, subject to such broker's particular processes.

About OneMedNet Corporation

OneMedNet Corporation is revolutionizing Real-World Data (RWD) through its iRWD™ platform, delivering regulatory decision-grade, AI-ready datasets that include de-identified medical imaging alongside comprehensive clinical records. With a network spanning more than 2,300 sites and encompassing over 90 million patient journeys and 270 million studies, OneMedNet serves life sciences companies, medical device manufacturers, AI developers, and other innovators seeking high-quality, compliant healthcare data. The Company’s platform is powered by Palantir Foundry and supports applications ranging from drug development and regulatory submissions to foundational AI model training.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release are forward-looking statements. Forward-looking statements may describe our future plans and expectations and are based on the current beliefs, expectations and assumptions of the Company. These statements generally use terms such as “believe,” “expect,” “may,” “will,” “should,” “could,” “seek,” “intend,” “plan,” “estimate,” “anticipate” or similar terms. Examples of forward-looking statements in this press release include but are not limited to statements about the timing and implementation of the Reverse Stock Split and the commencement of trading of the Company’s post-split common stock, the impact of the Reverse Stock Split on the Company’s securityholders, the potential for the Company to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market and the expected number of shares of common stock to be issued and outstanding following the Reverse Stock Split.

We urge you to consider those factors, and the other risks and uncertainties described in our most recent Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”), any subsequently filed quarterly reports on Form 10-Q as well as in other documents that may have been subsequently filed by the Company, from time to time, with the SEC, in evaluating our forward-looking statements. In addition, any forward-looking statements represent the Company’ views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. The Company does not assume any obligation to update any forward-looking statements unless required by law.

OneMedNet Contacts:

Michael Wong, VP Marketing
Email: michael.wong@onemednet.com
SOURCE: ONEMEDNET CORPORATION

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When does OneMedNet’s 1-for-10 reverse stock split take effect?

The 1-for-10 reverse split takes effect at 12:01 a.m. Eastern Time on September 29, 2026. Split-adjusted trading is expected to begin when markets open that day.

What happens to fractional shares and brokerage holdings in OneMedNet’s reverse split?

No fractional shares will be issued; any resulting fraction will be rounded up to a whole share. Holders of electronic shares need take no action. Holdings through a bank, broker or other nominee will be adjusted, subject to that institution’s processes.

How will OneMedNet’s reverse split affect equity awards and warrants?

The split will proportionately adjust shares available under OneMedNet’s equity incentive plans. The exercise price and number of shares underlying outstanding restricted stock units, warrants and other equity instruments will also be adjusted in accordance with their terms.